

The Loss of Exclusivity Planning Course for Pharma
With Dr Neal Hansen & James Kettlewell
Course Details
THE CONTENT
With over $180bn in pharmaceutical company revenues expected to lose exclusivity before 2030, some of the largest brands in the industry will face significant late-lifecycle challenges in the coming years. Yet there is still limited understanding of what Loss of Exclusivity (LOE) really means among pharma professionals — and, more importantly, an underappreciation of the opportunities to continue delivering sustainable value for patients even in the face of generic or biosimilar competition.
This course provides a practical approach to understanding and preparing for LOE, rooted in real-life industry case studies & tangible examples of effective (and ineffective) LOE planning. You will learn how to anticipate the likely impact of LOE, understand the diversity in how post-LOE dynamics evolve across global markets, and be introduced to the processes, frameworks, and tools that enable the effective navigation of LOE events.
If you want to ensure that your brand is adequately prepared for the challenges and opportunities posed by LOE, this course is a must-attend!
THE EXPERTS
Dr Neal Hansen is a dynamic and engaging speaker. You will leave his course inspired and equipped with actionable insights!
Founder and CEO of Align Strategy, an international pharma consultancy with over 25 years of experience in advising the pharma industry on LLC management & navigating LOE events.
Co-author of Pharmaceutical Lifecycle Management – Making the Most of Each and Every Brand (Wiley & Sons, 2012), and a long-standing CELforPharma faculty member who has always been highly rated by participants for his vast experience and teaching style.
Joining Neal will be James Kettlewell:
A Principal Consultant at Align Strategy with over a decade of experience supporting global pharmaceutical and biotech companies in addressing their key strategic challenges.
James has extensive experience in supporting clients planning for LOE, through the development and implementation of planning frameworks and tools, and brings knowledge of the post-LOE dynamics of a diverse range of global markets.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma professionals with responsibility for lifecycle-management planning at the global, regional or local levels, across a wide range of functions including commercial, marketing, medical, access, and clinical. It is particularly valuable for those working with brands expecting to face generic or biosimilar competition within the next 7-8 years — the earlier LOE planning begins, the more opportunities can be realised.
Through a mix of expert-led teaching and interactive exercises, you will learn the key principles that determine when Loss of Exclusivity (LOE) occurs and how it affects a brand. You will also be introduced to practical frameworks and tools that support strong LOE planning. The course format includes real-life case studies, structured group exercises and peer discussions. These activities are designed to help you build the practical skills needed to prepare for LOE and to execute effective plans.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
What LOE means and the factors that determine both its timing and its impact.
How and why markets can behave very differently after generics or biosimilars enter, both across countries and within a single market.
The proven processes and frameworks that support effective, cross-functional LOE planning at the global, regional, and local levels, and that ensure buy-in at every stage.
The toolkit of tactical options available for late-lifecycle planning, illustrated with real-world case studies, and how to judge which options are most relevant for your brand.
The critical success factors for building strong LOE plans that support your brand through and beyond the entry of generics and biosimilars.
| Welcome & Introductions (~15 min) |
| Loss of Exclusivity 101: The Fundamentals of Biosimilar & Generic Entry (~45 min) |
|
| Demystifying Local Post-LOE Dynamics (~1 h 15 min) |
|
| The Blueprint for LOE Success (~45 min) |
|
| Lunch Break |
| The Essential LOE Planning Toolkit (~1 h) |
|
| LOE Planning in Action (~1 h 15 min) |
|
| LOE Planning Excellence: Validating & Stress-Testing Your Plan (~45 min) |
|
| Wrap-Up and Key Takeaways (~15 min) |
UPCOMING DATES & FORMATS - FEES
23 June 2026
Live online
Early bird € 1 570
(until 22/05/2026)
(Full fee € 1 770)
17 November 2026
Live online
Early bird € 1 570
(until 16/10/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.
Course Details
Upcoming Session
23 June 2026, Live online
Early bird € 1 570
(until 22/05/2026)
(Full fee € 1 770)
Prices are excl. VAT
THE CONTENT
With over $180bn in pharmaceutical company revenues expected to lose exclusivity before 2030, some of the largest brands in the industry will face significant late-lifecycle challenges in the coming years. Yet there is still limited understanding of what Loss of Exclusivity (LOE) really means among pharma professionals — and, more importantly, an underappreciation of the opportunities to continue delivering sustainable value for patients even in the face of generic or biosimilar competition.
This course provides a practical approach to understanding and preparing for LOE, rooted in real-life industry case studies & tangible examples of effective (and ineffective) LOE planning. You will learn how to anticipate the likely impact of LOE, understand the diversity in how post-LOE dynamics evolve across global markets, and be introduced to the processes, frameworks, and tools that enable the effective navigation of LOE events.
If you want to ensure that your brand is adequately prepared for the challenges and opportunities posed by LOE, this course is a must-attend!
THE EXPERTS
Dr Neal Hansen is a dynamic and engaging speaker. You will leave his course inspired and equipped with actionable insights!
Founder and CEO of Align Strategy, an international pharma consultancy with over 25 years of experience in advising the pharma industry on LLC management & navigating LOE events.
Co-author of Pharmaceutical Lifecycle Management – Making the Most of Each and Every Brand (Wiley & Sons, 2012), and a long-standing CELforPharma faculty member who has always been highly rated by participants for his vast experience and teaching style.
Joining Neal will be James Kettlewell:
A Principal Consultant at Align Strategy with over a decade of experience supporting global pharmaceutical and biotech companies in addressing their key strategic challenges.
James has extensive experience in supporting clients planning for LOE, through the development and implementation of planning frameworks and tools, and brings knowledge of the post-LOE dynamics of a diverse range of global markets.
THE AUDIENCE & INTERACTIVE LEARNING FORMAT
This course is designed for pharma professionals with responsibility for lifecycle-management planning at the global, regional or local levels, across a wide range of functions including commercial, marketing, medical, access, and clinical. It is particularly valuable for those working with brands expecting to face generic or biosimilar competition within the next 7-8 years — the earlier LOE planning begins, the more opportunities can be realised.
Through a mix of expert-led teaching and interactive exercises, you will learn the key principles that determine when Loss of Exclusivity (LOE) occurs and how it affects a brand. You will also be introduced to practical frameworks and tools that support strong LOE planning. The course format includes real-life case studies, structured group exercises and peer discussions. These activities are designed to help you build the practical skills needed to prepare for LOE and to execute effective plans.
If you are a consultant, please contact Annelies Swaan, who will check with the faculty whether you can attend.
What LOE means and the factors that determine both its timing and its impact.
How and why markets can behave very differently after generics or biosimilars enter, both across countries and within a single market.
The proven processes and frameworks that support effective, cross-functional LOE planning at the global, regional, and local levels, and that ensure buy-in at every stage.
The toolkit of tactical options available for late-lifecycle planning, illustrated with real-world case studies, and how to judge which options are most relevant for your brand.
The critical success factors for building strong LOE plans that support your brand through and beyond the entry of generics and biosimilars.
| Welcome & Introductions (~15 min) |
| Loss of Exclusivity 101: The Fundamentals of Biosimilar & Generic Entry (~45 min) |
|
| Demystifying Local Post-LOE Dynamics (~1 h 15 min) |
|
| The Blueprint for LOE Success (~45 min) |
|
| Lunch Break |
| The Essential LOE Planning Toolkit (~1 h) |
|
| LOE Planning in Action (~1 h 15 min) |
|
| LOE Planning Excellence: Validating & Stress-Testing Your Plan (~45 min) |
|
| Wrap-Up and Key Takeaways (~15 min) |
UPCOMING DATES & FORMATS - FEES
23 June 2026
Live online
Early bird € 1 570
(until 22/05/2026)
(Full fee € 1 770)
17 November 2026
Live online
Early bird € 1 570
(until 16/10/2026)
(Full fee € 1 770)
TIMING & LOCATION
Live Online: Zoom sessions between 9 AM and 5 PM CET (Brussels, Amsterdam, Paris time).
All practical details will be shared upon registration. For any questions, please contact Margherita Mutto or call +32 472 03 11 38 .
GROUP DISCOUNTS
Team discounts can be offered to 2 or more delegates from the same company.
Email Annelies Swaan for more details.
HOW TO REGISTER
Click the green “Register” button on your preferred course session.
The registration wizard will guide you through the process.Alternatively, download the offline registration form and send the completed form to Annelies Swaan.
PAYMENT OPTIONS
Credit Card: You’ll receive a secure payment link with your invoice (no immediate payment required).
Bank Transfer: Details provided with your invoice.
For help with registration, email Annelies Swaan or contact her by phone at +32 486 98 52 49.
INCLUDED IN THE REGISTRATION FEE
Access to a highly interactive, small-group online course (max 20 participants)
Course materials in both digital and hard copy format
Certificate of attendance signed by the experts and CELforPharma
VAT INFORMATION
Prices exclude VAT. VAT application depends on course format and your location:
Face-to-Face in Belgium: 21% Belgian VAT applies
Live online courses: The applicable VAT depends on your invoicing address. Contact your local VAT office for refund procedures where applicable.
TRANSFER & CANCELLATION POLICY
Flexible Transfer
If a registrant is unable to attend the scheduled course, they can avoid any cancellation charges by providing a suitable replacement participant.
Alternatively, the registrant may transfer once, on a 'space-available' basis and at no extra cost, to another course of the same value held within one year of the original course date, provided this is done at least three weeks prior to the event.
Registration Cancellation
Less than 14 days prior to the course date: The registrant is liable to pay the full invoiced registration fee.
Between 15 and 30 days prior to the course date: The registrant is liable to pay 50% of the invoiced registration fee.
More than 30 days prior to the course date: The registrant is liable to pay a cancellation fee of € 450 per registrant.
If a registrant postpones their participation to a future course and subsequently cancels again, no refund will be issued for the registration fees.









